Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Bernstein

Showing results (241-250 of 698) with videos related to

Pageof 70
Sort By:
Springerplus|September 5, 2014
The 24-h FEV1 time profile of olodaterol once daily via Respimat® and formoterol twice daily via Aerolizer® in patients with GOLD 2-4 COPD: results from two 6-week crossover studiesGregory J Feldman, Jonathan A Bernstein, Alan Hamilton, et al.
The Journal of Allergy and Clinical Immunology|February 1, 2008
Allergists' attitudes toward environmental control: insights into its current application in clinical practiceDominique M Brandt, Linda Levin, Elizabeth Matsui, et al.
Frontiers in Immunology|January 12, 2019
Leveraging Multilayered "Omics" Data for Atopic Dermatitis: A Road Map to Precision MedicineDebajyoti Ghosh, Jonathan A Bernstein, Gurjit K Khurana Hershey, et al.
Clinical and Translational Allergy|May 25, 2023
Current challenges and future opportunities in patient-focused management of hereditary angioedema: A narrative reviewAnete S Grumach, Noga Gadir, Aharon Kessel, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|November 8, 2023
Association among friendship skills, involvement in after-school activities, and flourishing for adolescents with asthma and comorbid emotional and behavioral problemsLaura Nabors, Ashley L Merianos, Cathleen Odar Stough, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 1, 2011
Alteration of brain activation patterns in nonallergic rhinitis patients using functional magnetic resonance imaging before and after treatment with intranasal azelastineJonathan A Bernstein, Lloyd Hastings, Erin L Boespflug, et al.
Pediatric Neurology|November 14, 2020
Combined Genome Sequencing and RNA Analysis Reveals and Characterizes a Deep Intronic Variant in IGHMBP2 in a Patient With Spinal Muscular Atrophy With Respiratory Distress Type 1Ethan E Bodle, Wenmiao Zhu, Frances Velez-Bartolomei, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 7, 2019
Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancyDumitru Moldovan, Jonathan A Bernstein, Roman Hakl, et al.
Regulatory Toxicology and Pharmacology : RTP|September 4, 2017
Chemical-induced asthma and the role of clinical, toxicological, exposure and epidemiological research in regulatory and hazard characterization approachesMelissa J Vincent, Jonathan A Bernstein, David Basketter, et al.
Expert Opinion on Biological Therapy|February 13, 2018
Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of 'real-world' evidenceJonathan A Bernstein, Abhishek Kavati, Michael D Tharp, et al.
Pageof 70

Showing results (241-250 of 698) with videos related to

Sort By:
Pageof 70
Springerplus|September 5, 2014
The 24-h FEV1 time profile of olodaterol once daily via Respimat® and formoterol twice daily via Aerolizer® in patients with GOLD 2-4 COPD: results from two 6-week crossover studiesGregory J Feldman, Jonathan A Bernstein, Alan Hamilton, et al.
The Journal of Allergy and Clinical Immunology|February 1, 2008
Allergists' attitudes toward environmental control: insights into its current application in clinical practiceDominique M Brandt, Linda Levin, Elizabeth Matsui, et al.
Frontiers in Immunology|January 12, 2019
Leveraging Multilayered "Omics" Data for Atopic Dermatitis: A Road Map to Precision MedicineDebajyoti Ghosh, Jonathan A Bernstein, Gurjit K Khurana Hershey, et al.
Clinical and Translational Allergy|May 25, 2023
Current challenges and future opportunities in patient-focused management of hereditary angioedema: A narrative reviewAnete S Grumach, Noga Gadir, Aharon Kessel, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|November 8, 2023
Association among friendship skills, involvement in after-school activities, and flourishing for adolescents with asthma and comorbid emotional and behavioral problemsLaura Nabors, Ashley L Merianos, Cathleen Odar Stough, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 1, 2011
Alteration of brain activation patterns in nonallergic rhinitis patients using functional magnetic resonance imaging before and after treatment with intranasal azelastineJonathan A Bernstein, Lloyd Hastings, Erin L Boespflug, et al.
Pediatric Neurology|November 14, 2020
Combined Genome Sequencing and RNA Analysis Reveals and Characterizes a Deep Intronic Variant in IGHMBP2 in a Patient With Spinal Muscular Atrophy With Respiratory Distress Type 1Ethan E Bodle, Wenmiao Zhu, Frances Velez-Bartolomei, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 7, 2019
Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancyDumitru Moldovan, Jonathan A Bernstein, Roman Hakl, et al.
Regulatory Toxicology and Pharmacology : RTP|September 4, 2017
Chemical-induced asthma and the role of clinical, toxicological, exposure and epidemiological research in regulatory and hazard characterization approachesMelissa J Vincent, Jonathan A Bernstein, David Basketter, et al.
Expert Opinion on Biological Therapy|February 13, 2018
Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of 'real-world' evidenceJonathan A Bernstein, Abhishek Kavati, Michael D Tharp, et al.
Pageof 70